The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. (2014)
Attributed to:
Characterisation of primitive stem cell-like canine cancer cells: identification of therapeutic targets through genomics
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12917-014-0184-9
PubMed Identifier: 25190452
Publication URI: http://europepmc.org/abstract/MED/25190452
Type: Journal Article/Review
Volume: 10
Parent Publication: BMC veterinary research
ISSN: 1746-6148